[Comparison of the effectiveness of idarubicin (Zavedos) and mitoxantrone (Refador) in induction therapy of acute myeloid leukemia in elderly patients (55-75) (a prospective multicenter randomized study conducted 1998-2000]. / Srovnání úcinnosti idarubicinu (Zavedos) a mitoxantronu (Refador) v indukcní lécbe akutní myeloidní leukémie nemocných seniorského veku (55-75 let) (prospektivní multicentrická randomizovaná studie 1998-2000).
Vnitr Lek
; 47 Suppl 1: 48-56, 2001 Sep.
Article
in Cs
| MEDLINE
| ID: mdl-11693063
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Idarubicin
/
Leukemia, Myeloid
/
Mitoxantrone
/
Antineoplastic Agents
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
Cs
Journal:
Vnitr Lek
Year:
2001
Document type:
Article
Country of publication:
Czech Republic